Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Modular Phase I/II, Open-label, Multicentre Study to Assess AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Haematological Malignancies

NCT04630756 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04630756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04630756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Modular Phase I/II, Open-label, Multicentre Study to Assess AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Haematological Malignancies
Lead sponsor
AstraZeneca
Phase
Phase 1/2
Overall status
Completed
Start date
February 17, 2021
Completion date
February 27, 2025
Enrollment
40 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

advanced haematological malignancies